Filing Details
- Accession Number:
- 0000059478-18-000167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-14 16:08:43
- Reporting Period:
- 2018-06-14
- Accepted Time:
- 2018-06-14 16:08:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741474 | Daniel Skovronsky | Lilly Corporate Center Indianapolis IN 46285 | Svp, Cso, And Pres. Lrl | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-14 | 10,000 | $86.22 | 55,199 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
